Amir Hassan (he/him) is an Endocrinologist in Houston, TX with over 16 years of experience. What is your opinion of Amir Hassan? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Amir Hassan has received over $174,571 which includes payments from the following companies:
$101,773.16 from Boehringer Ingelheim Pharmaceuticals, Inc.
$33,210.12 from Amarin Pharma Inc.
$27,615.94 from LILLY USA, LLC
$4,973.86 from Novo Nordisk Inc
$978.83 from Amgen Inc.
$616.29 from sanofi-aventis U.S. LLC
$542.82 from Merck Sharp & Dohme Corporation
$424.02 from Horizon Pharma plc
$382.94 from AstraZeneca Pharmaceuticals LP
$362.64 from E.R. Squibb & Sons, L.L.C.
$298.00 from Janssen Biotech, Inc.
$226.82 from Novartis Pharmaceuticals Corporation
$200.58 from Kowa Pharmaceuticals America, Inc.
$199.62 from Janssen Pharmaceuticals, Inc
$165.30 from AbbVie, Inc.
$164.57 from GlaxoSmithKline, LLC.
$162.96 from GENZYME CORPORATION
$133.97 from Valeant Pharmaceuticals North America LLC
$133.80 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$125.42 from Corcept Therapeutics
Payments received by Amir Hassan were from the following categories:
$104,262.50 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!